Skin Cancer Research Today is a free monthly online journal that collates and summarizes the latest research about Skin Cancer, including details on identification, causes, prevention, treatment.

Volume 4 (2007), Issue 3 (March)

1. Metabotropic glutamate receptor 1 and glutamate signaling in human melanoma.
   Cancer Res, 67(5): 2298-305. [Abstract] [Full-text]
2. HLA class I expression in metastatic melanoma correlates with tumor development during autologous vaccination.
   Cancer Immunol Immunother, 56(5): 709-17. [Abstract] [Full-text]
3. Monitoring antitumor efficacy of rapamycin in Kaposi sarcoma.
   Am J Kidney Dis, 49(3): 462-70. [Abstract] [Full-text]
4. Non-inflammatory skin involvement in breast cancer, histologically proven but without the clinical and histological T4 category features.
   J Surg Oncol, 95(4): 291-7. [Abstract] [Full-text]
5. Distinct mechanisms of loss of IFN-gamma mediated HLA class I inducibility in two melanoma cell lines.
   BMC Cancer, 7: 34. [Abstract] [Full-text]
6. The skin cancer index: clinical responsiveness and predictors of quality of life.
   Laryngoscope, 117(3): 399-405. [Abstract] [Full-text]
7. Predictors of survival and recurrence in the surgical treatment of merkel cell carcinoma of the extremities.
   J Surg Oncol, 95(3): 229-34. [Abstract] [Full-text]
8. Ambient UV, personal sun exposure and risk of multiple primary melanomas.
   Cancer Causes Control, 18(3): 295-304. [Abstract] [Full-text]
9. Glycoconjugate profiling of primary melanoma and its sentinel node and distant metastases: implications for diagnosis and pathophysiology of metastases.
   Cancer Lett, 248(1): 68-80. [Abstract] [Full-text]
10. Congenital dermatofibrosarcoma protuberans: 30 years of follow-up.
    J Dtsch Dermatol Ges, 5(3): 223-5. [Abstract] [Full-text]
11. Dendritic cell-based immunotherapy of malignant melanoma: success and limitations.
    J Dtsch Dermatol Ges, 5(3): 190-6. [Abstract] [Full-text]
12. Efficacy and tolerability of currently available therapies for the mycosis fungoides and Sezary syndrome variants of cutaneous T-cell lymphoma.
    Cancer Treat Rev, 33(2): 146-60. [Abstract] [Full-text]
13. Novel treatment strategies for malignant melanoma: a new beginning?
    Crit Rev Oncol Hematol, 62(1): 16-22. [Abstract] [Full-text]
14. Giant cell fibroblastoma: an update and addition of 86 new cases from the Armed Forces Institute of Pathology, in honor of Dr. Franz M. Enzinger.
    Ann Diagn Pathol, 11(2): 81-8. [Abstract] [Full-text]
15. Cisplatin encapsulated in phosphatidylethanolamine liposomes enhances the in vitro cytotoxicity and in vivo intratumor drug accumulation against melanomas.
    J Dermatol Sci, 46(1): 11-20. [Abstract] [Full-text]
16. A case of multiple epitrichial sweat gland ductal carcinomas in a horse.
    Vet Dermatol, 18(2): 134-7. [Abstract] [Full-text]
17. Congenital lipoblastoma in a neonate calf: first report in veterinary literature.
    Vet Dermatol, 18(2): 130-3. [Abstract] [Full-text]
18. Investigation on the association between atopic dermatitis and the development of mycosis fungoides in dogs: a retrospective case-control study.
    Vet Dermatol, 18(2): 101-6. [Abstract] [Full-text]
19. The use of tissue inhibitors of matrix metalloproteinases to increase the efficacy of a tumor necrosis factor/interferon gamma antitumor therapy.
    Cancer Gene Ther, 14(4): 372-9. [Abstract] [Full-text]
20. Putative cancer stem cells in cutaneous malignancies.
    Exp Dermatol, 16(4): 297-301. [Abstract] [Full-text]
21. Distinct clinical and pathological features are associated with the BRAF(T1799A(V600E)) mutation in primary melanoma.
    J Invest Dermatol, 127(4): 900-5. [Abstract] [Full-text]
22. TIM-3 is expressed in melanoma cells and is upregulated in TGF-beta stimulated mast cells.
    J Invest Dermatol, 127(4): 906-14. [Abstract] [Full-text]
23. Risk factors for histological types and anatomic sites of cutaneous basal-cell carcinoma: an italian case-control study.
    J Invest Dermatol, 127(4): 935-44. [Abstract] [Full-text]
24. Genome-wide loss of heterozygosity and copy number analysis in melanoma using high-density single-nucleotide polymorphism arrays.
    Cancer Res, 67(6): 2632-42. [Abstract] [Full-text]
25. Dominant-negative activator protein 1 (TAM67) targets cyclooxygenase-2 and osteopontin under conditions in which it specifically inhibits tumorigenesis.
    Cancer Res, 67(6): 2430-8. [Abstract] [Full-text]
26. Polymorphisms in COX-2, NSAID use and risk of basal cell carcinoma in a prospective study of Danes.
    Mutat Res, 617(1): 138-46. [Abstract] [Full-text]
27. Identification of high-risk patients among those diagnosed with thin cutaneous melanomas.
    J Clin Oncol, 25(9): 1129-34. [Abstract] [Full-text]
28. Adjuvant radiation therapy is associated with improved survival in Merkel cell carcinoma of the skin.
    J Clin Oncol, 25(9): 1043-7. [Abstract] [Full-text]
29. Surgical management of melanoma of the gallbladder: a report of 13 cases and review of the literature.
    Am J Surg, 193(4): 493-7. [Abstract] [Full-text]
30. Immunohistochemical staining for CD45R isoforms in paraffin sections to diagnose mycosis fungoides-type cutaneous T-cell lymphoma.
    J Am Acad Dermatol, 56(4): 635-42. [Abstract] [Full-text]
31. New prognostic relevant factors in primary cutaneous diffuse large B-cell lymphomas.
    J Am Acad Dermatol, 56(4): 588-97. [Abstract] [Full-text]
32. Mature T-cell leukemias including T-prolymphocytic leukemia, adult T-cell leukemia/lymphoma, and Sézary syndrome.
    Am J Clin Pathol, 127(4): 496-510. [Abstract] [Full-text]
33. A case of epidermodysplasia verruciformis with squamous cell carcinomas on non-sun-exposed areas of skin.
    Arch Iran Med, 10(2): 261-3. [Abstract] [Full-text]
34. Metastatic carcinoma of the ovary presenting as zosteriform lesions.
    Arch Iran Med, 10(2): 250-2. [Abstract] [Full-text]
35. Pigmented Bowen's disease of the finger mimicking malignant melanoma.
    Arch Iran Med, 10(2): 255-7. [Abstract] [Full-text]
36. Molecular markers of circulating melanoma cells.
    Pigment Cell Res, 20(2): 80-91. [Abstract] [Full-text]
37. Inhibition of urokinase-type plasminogen activator receptor induces apoptosis in melanoma cells by activation of p53.
    Cell Death Differ, 14(4): 818-29. [Abstract] [Full-text]
38. Melanocytic skin lesions and pregnancy: digital dermoscopy analysis.
    Skin Res Technol, 13(2): 143-7. [Abstract] [Full-text]
39. Digital dermoscopy in clinical practise: a three-centre analysis.
    Skin Res Technol, 13(2): 133-42. [Abstract] [Full-text]
40. Changes in the dermoscopic appearance of melanocytic naevi after photochemotherapy or narrow-band ultraviolet B phototherapy.
    J Eur Acad Dermatol Venereol, 21(4): 526-31. [Abstract] [Full-text]
41. Awareness, knowledge and attitudes towards sun protection among skin cancer-treated patients in France.
    J Eur Acad Dermatol Venereol, 21(4): 520-5. [Abstract] [Full-text]
42. Natural history of invasive cutaneous melanoma in Styria, Austria 2001-2003.
    J Dtsch Dermatol Ges, 5(4): 293-9. [Abstract] [Full-text]
43. Study of the reactive dendritic cells in small B-cell lymphoproliferations of the skin.
    Virchows Arch, 450(4): 441-7. [Abstract] [Full-text]
44. Matrix Metalloproteinase-9 (MMP-9) polymorphisms in patients with cutaneous malignant melanoma.
    BMC Med Genet, 8: 10. [Abstract] [Full-text]
45. Mcl-1, Bcl-XL and Stat3 expression are associated with progression of melanoma whereas Bcl-2, AP-2 and MITF levels decrease during progression of melanoma.
    Mod Pathol, 20(4): 416-26. [Abstract] [Full-text]
46. Cutaneous oncocytoma - a report of three cases and review of the literature.
    J Cutan Pathol, 34(4): 355-9. [Abstract] [Full-text]
47. Mycobacterial spindle cell pseudotumor of the skin.
    J Cutan Pathol, 34(4): 346-51. [Abstract] [Full-text]
48. Fibrosis in regressing melanoma versus nonfibrosis in halo nevus upon melanocyte disappearance: could it be related to a different cytokine microenvironment?
    J Cutan Pathol, 34(4): 301-8. [Abstract] [Full-text]
49. Histological evolution of lentiginous melanoma: a report of five new cases.
    J Cutan Pathol, 34(4): 296-300. [Abstract] [Full-text]
50. Detection of tyrosinase mRNA in the sentinel lymph nodes of melanoma patients is not a predictor of short-term disease recurrence.
    Mod Pathol, 20(4): 427-34. [Abstract] [Full-text]
51. Positive regulation of tumor necrosis factor-alpha by ganglioside GM3 through Akt in mouse melanoma B16 cells.
    Biochem Biophys Res Commun, 356(2): 438-43. [Abstract] [Full-text]
52. Hypoxia influences vasculogenic mimicry channel formation and tumor invasion-related protein expression in melanoma.
    Cancer Lett, 249(2): 188-97. [Abstract] [Full-text]
53. Detailed site distribution of melanoma and sunlight exposure: aetiological patterns from a Swiss series.
    Ann Oncol, 18(4): 789-94. [Abstract] [Full-text]
54. Decreased risk of prostate cancer after skin cancer diagnosis: a protective role of ultraviolet radiation?
    Am J Epidemiol, 165(8): 966-72. [Abstract] [Full-text]
55. The association between non-melanoma skin cancer and osteoporotic fractures--a population-based record linkage study.
    Osteoporos Int, 18(5): 687-92. [Abstract] [Full-text]

© 2004-2012 Skin Cancer Research Today. All Rights Reserved.